|
|
FIN 2012
COI 4.00 %
*
Breed relevant health information:
Elbows
normal
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
Result of general cardiovascular health checks
OK
|
FIN 2006
COI 2.87 %
*
Breed relevant health information:
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
FIN 2006
COI 0.89 %
*
Breed relevant health information:
Elbows
normal
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
Year of death:
2021
Cause of death:
Old age (unspecified cause of death)
|
|||
|
SWE 2011
COI 0.94 %
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Fair / B1 / 4-6 / B / 11-18
Progressive retinal atrophy (prcd-PRA)
N/mut (carrier)
|
||
FIN 2008
COI 5.09 %
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
|||
NOR 2019
COI 1.24 %
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
NOR 2015
COI 0.25 %
Breed relevant health information:
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
-
2/12/2015
|
NOR 2013
COI 1.17 %
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
|
|
|||
NOR 2017
COI 0.72 %
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Mild / C1 / 9-12 / C / 26-35
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
-
25/3/2019
|
|
||
|
Date of birth | Year of death | Cause of death | Canine Multifocal Retinopathy 3 (CMR3) | Degenerative myelopathy (DM) | Elbows | Glycogen storage disease type II (Pompe disease) (GSDII) | Hips | Progressive retinal atrophy (prcd-PRA) | Result of general cardiovascular health checks | |
---|---|---|---|---|---|---|---|---|---|---|
Parents | ||||||||||
Turpo av Vintervidda
|
17 Jun 2016 | |||||||||
Alnopa Pöytävuori
|
11 May 2019 | N/N (clear) | N/N (clear) | |||||||
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Siblings | ||||||||||
Alnopa Helinä-Keiju
|
9 Apr 2021 | N/N (clear) | Excellent / A1 / 0 / A / 0-4 (no >3/hip) | |||||||
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
|
||||||||||
Alnopa Mikki Hiiri
|
9 Apr 2021 | |||||||||
Alnopa Musta Pekka
|
9 Apr 2021 | |||||||||
Alnopa Prinssi Juhana
|
9 Apr 2021 | N/N (clear) | Mild / C1 / 9-12 / C / 26-35 | N/N (clear) | ||||||
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Mild / C1 / 9-12 / C / 26-35
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Alnopa Risto Reipas
|
9 Apr 2021 | |||||||||
Alnopa Samu Sirkka
|
9 Apr 2021 | |||||||||
Half siblings (sire) | ||||||||||
Half siblings (dam) | ||||||||||
Alnopa Miisa
|
31 Aug 2024 | |||||||||
Alnopa Mörkö
|
31 Aug 2024 | |||||||||
Alnopa Mymmeli
|
31 Aug 2024 | |||||||||
Alnopa Niiskuneiti
|
31 Aug 2024 | |||||||||
Alnopa Ninni
|
31 Aug 2024 | |||||||||
Alnopa Pikku Myy
|
31 Aug 2024 | |||||||||
Offspring |